BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1460 related articles for article (PubMed ID: 16499636)

  • 21. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells.
    Wilcock LK; Francis JN; Durham SR
    Clin Exp Allergy; 2004 Sep; 34(9):1373-8. PubMed ID: 15347369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublingual immunotherapy efficacy of Dermatophagoides farinae vaccine in a murine asthma model.
    Yu HQ; Li XH; Guo H; Liu ZG; Ran PX; Ji KM; Wang J
    Int Arch Allergy Immunol; 2010; 152(1):41-8. PubMed ID: 19940504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma.
    Sin B; Misirligil Z; Aybay C; Gürbüz L; Imir T
    J Investig Allergol Clin Immunol; 1996; 6(6):341-7. PubMed ID: 9015776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.
    Chen ZG; Li M; Chen YF; Ji JZ; Li YT; Chen W; Chen FH; Chen H
    Chin Med J (Engl); 2009 May; 122(10):1157-61. PubMed ID: 19493463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
    Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
    J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Der p1-specific antibody levels in children with allergic airway disease and healthy controls.
    Aydogan M; Mete N; Yazi D; Akkoc T; Ozdemir C; Blaser K; Akdis M; Akdis C; Bahceciler N; Barlan I
    Pediatr Allergy Immunol; 2007 Jun; 18(4):320-5. PubMed ID: 17584311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma.
    Samson KT; Minoguchi K; Tanaka A; Oda N; Yokoe T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2006 Apr; 36(4):475-82. PubMed ID: 16630152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH; Lin YH; Yang J; Guo W
    Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical efficacy and immunological changes in children with allergic rhinitis receiving specific immunotherapy with Dermatophagoides pteronyssinus].
    Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Wang Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 46(1):36-9. PubMed ID: 21429334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes.
    O'Brien RM; Byron KA; Varigos GA; Thomas WR
    Clin Exp Allergy; 1997 Jan; 27(1):46-51. PubMed ID: 9117880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, Antigen P1: comparison of patients with asthma, atopic dermatitis, and perennial rhinitis.
    Rawle FC; Mitchell EB; Platts-Mills TA
    J Immunol; 1984 Jul; 133(1):195-201. PubMed ID: 6609976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ CD30+ T cells perpetuate IL-5 production in Dermatophagoides pteronyssinus allergic patients.
    Garfias Y; Ortiz B; Hernández J; Magaña D; Becerril-Angeles M; Zenteno E; Lascurain R
    Allergy; 2006 Jan; 61(1):27-34. PubMed ID: 16364153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria.
    Hisbergues M; Magi M; Rigaux P; Steuve J; Garcia L; Goudercourt D; Pot B; Pestel J; Jacquet A
    Clin Exp Allergy; 2007 Sep; 37(9):1286-95. PubMed ID: 17845408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
    Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy.
    Oda N; Yamashita N; Minoguchi K; Takeno M; Kaneko S; Sakane T; Adachi M
    Cell Immunol; 1998 Nov; 190(1):43-50. PubMed ID: 9826445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.